Clinical Trials Browser

Phase 2 × Stomach Neoplasms × Ipilimumab × Clear all

NCT03409848 2022-05-18

INTEGA

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT03342417 2021-11-09

Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients

Phase 2 Terminated

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Stomach Neoplasms